BRPI0708554B8 - uso de um composto - Google Patents

uso de um composto

Info

Publication number
BRPI0708554B8
BRPI0708554B8 BRPI0708554A BRPI0708554A BRPI0708554B8 BR PI0708554 B8 BRPI0708554 B8 BR PI0708554B8 BR PI0708554 A BRPI0708554 A BR PI0708554A BR PI0708554 A BRPI0708554 A BR PI0708554A BR PI0708554 B8 BRPI0708554 B8 BR PI0708554B8
Authority
BR
Brazil
Prior art keywords
kaempferia
siphonochilus
plant
cienkowskiella
aethiopica
Prior art date
Application number
BRPI0708554A
Other languages
English (en)
Inventor
Wadiwala Ebrahim
Fouché Gerda
Gabriël Jozua Ackerman Louis
Mikhailovna Van Der Merwe Marina
Marthinus Horak Roelof
Jaichand Maharaj Vinesh
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csir filed Critical Csir
Publication of BRPI0708554A2 publication Critical patent/BRPI0708554A2/pt
Publication of BRPI0708554B1 publication Critical patent/BRPI0708554B1/pt
Publication of BRPI0708554B8 publication Critical patent/BRPI0708554B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

uso de um extrato da espécie de planta siphonochilus aethiopicus, composição, e, uso de um composto. a invenção provê o uso de pelo menos uma planta selecionada de plantas da família zingiberaceae, na preparação de um medicamento para uso no tratamento ou profilaxia de doenças alérgicas. a planta é opcionalmente selecionada dos gêneros siphonochilus, kaempferia, cienkowskia e cienkowskiella e a espécie é opcionalmente selecionada de siphonochilus aethiopicus, siphonochilus natalensis, kaempferia aethiopica, kaempferia natalensis, kaempferia ethelae, cienkowskia aethiopica e cienkowskiella aethiopica. a doença alérgica é selecionada de asma e atopia.
BRPI0708554A 2006-03-03 2007-02-28 uso de um composto BRPI0708554B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ZA2006/01860 2006-03-03
ZA200601860 2006-03-03
PCT/IB2007/050649 WO2007113698A2 (en) 2006-03-03 2007-02-28 Preventative treatment and remission of allergic diseases

Publications (3)

Publication Number Publication Date
BRPI0708554A2 BRPI0708554A2 (pt) 2011-05-31
BRPI0708554B1 BRPI0708554B1 (pt) 2021-01-19
BRPI0708554B8 true BRPI0708554B8 (pt) 2021-05-25

Family

ID=38521466

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0708554A BRPI0708554B8 (pt) 2006-03-03 2007-02-28 uso de um composto

Country Status (8)

Country Link
US (2) US20090082433A1 (pt)
EP (1) EP2007408B1 (pt)
CN (1) CN101432009B (pt)
AP (1) AP2893A (pt)
BR (1) BRPI0708554B8 (pt)
RU (1) RU2008137281A (pt)
WO (1) WO2007113698A2 (pt)
ZA (1) ZA200807874B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012018430A1 (en) 2010-07-26 2012-02-09 Seven Networks, Inc. Mobile network traffic coordination across multiple applications
WO2012024030A2 (en) 2010-07-26 2012-02-23 Seven Networks, Inc. Context aware traffic management for resource conservation in a wireless network
WO2013015835A1 (en) 2011-07-22 2013-01-31 Seven Networks, Inc. Mobile application traffic optimization
WO2013150406A2 (en) * 2012-04-04 2013-10-10 Integral Bioceuticals (Pty) Ltd Siphonochilone and related compounds and uses thereof
PL3008946T3 (pl) 2013-06-11 2019-02-28 Seven Networks Llc Przenoszenie ruchu aplikacji do współdzielonego kanału łączności w celu zoptymalizowania sygnału w sieci bezprzewodowej dla ruchu wykorzystującego protokoły własnościowe i nie-własnościowe

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09124677A (ja) * 1995-11-01 1997-05-13 Eba Keshohin:Kk ゲットウを用いた組成物及びその製造方法
JPH09143086A (ja) * 1995-11-22 1997-06-03 San Eng:Kk 皮膚疾患治療剤及び化粧料
HUP0102048A3 (en) * 1998-04-16 2002-12-28 Eurovita As Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga and their use
WO2001030367A1 (en) * 1999-10-27 2001-05-03 Shiseido Company, Ltd. Platelet-activating factor antagonists and dermatological compositions for external use containing the same
JP2001187725A (ja) * 2000-01-06 2001-07-10 Pola Chem Ind Inc ストレス予防剤及びそれを含有してなる皮膚外用剤
JP2001192338A (ja) * 2000-01-11 2001-07-17 Pola Chem Ind Inc ストレスの悪影響からの回復促進剤及びそれを含有してなる皮膚外用剤
JP2001261545A (ja) * 2000-03-21 2001-09-26 Shiseido Co Ltd 肌荒れ防止用皮膚外用剤
JP2003111581A (ja) * 2001-10-02 2003-04-15 Saburo Toyoda 健康飲料
JP2004269450A (ja) * 2003-03-11 2004-09-30 Shiseido Co Ltd 新規化合物およびケモカイン発現阻害剤
JP4495406B2 (ja) * 2003-04-21 2010-07-07 株式会社武蔵野免疫研究所 センダングサ属植物抽出物含有組成物
JP4073358B2 (ja) * 2003-04-28 2008-04-09 株式会社武蔵野免疫研究所 化粧品

Also Published As

Publication number Publication date
AP2893A (en) 2014-05-31
EP2007408B1 (en) 2019-05-01
EP2007408A2 (en) 2008-12-31
AP2008004630A0 (en) 2008-10-31
WO2007113698A3 (en) 2008-01-03
RU2008137281A (ru) 2010-04-10
WO2007113698A2 (en) 2007-10-11
CN101432009B (zh) 2012-03-21
ZA200807874B (en) 2009-04-29
US20100168227A1 (en) 2010-07-01
BRPI0708554A2 (pt) 2011-05-31
BRPI0708554B1 (pt) 2021-01-19
US20090082433A1 (en) 2009-03-26
CN101432009A (zh) 2009-05-13
US8158165B2 (en) 2012-04-17

Similar Documents

Publication Publication Date Title
BR112021006392A2 (pt) moduladores da alfa-1 antitripsina
CL2008000703A1 (es) Compuestos derivados de pirimidinas sustituidas; procedimiento para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar transtornos hematologicos.
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
CL2007002641A1 (es) Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias.
HN2012001162A (es) Triazolopiridinas
BRPI0806863B8 (pt) uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv
BRPI0713349A2 (pt) Inibidores de proteína tirosina fosfatase humana e métodos de utilização
UY32456A (es) Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
CL2008001002A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
BRPI0611717A2 (pt) composto, composiÇço farmacÊutica e uso do composto
BRPI1009842B8 (pt) uso de agonista de tlr9 e agonista de tlr2/6 na preparação de uma composição farmacêutica para tratamento, inibição ou atenuação de uma infecção microbiana, bem como composição farmaceuticamente aceitável compreendendo os referidos agonistas
BRPI0717845A2 (pt) Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos
CL2008001003A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008000887A1 (es) Compuestos derivados de 3-hidroxi-1h-pirimidin-4-ona o 3-hidroxi-piran-4-ona; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad neurodegenerativa causada por la presencia de
CL2008003712A1 (es) Compuestos derivados de tiadiazololoxifenilamidina o tiazoliloxifenilamidina; su procedimiento de preparacion; uso y procedimiento para combatir microorganismos no deseados; agente que comprende a dichos compuestos; compuestos intermediarios; y su procedimiento de preparacion.
AR071731A1 (es) Composiciones herbarias y metodos para el tratamiento de enfermedades hepaticas y metodos de obtencion
CL2007003480A1 (es) Compuestos derivados de tiazolo[5,4-c]piridin-4-ona sustituida; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento o prevencion de enfermedades relacionadas con la obesidad, como trastornos de la alimentacion, diab
ATE537819T1 (de) Nutrazeutische zusammensetzungen zur behandlung von muskelschwund
BRPI0708554B8 (pt) uso de um composto
BRPI0609765A8 (pt) mistura de isoalcano, método para a preparação da mesma, composição cosmética ou farmacêutica, e, uso de uma mistura de isoalcano
UY31143A1 (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas
CL2004000535A1 (es) Composicion farmaceutica que comprende rapamicina o un derivado de rapamicina y pimecrolimus; y su uso para el tratamiento de enfermedad inflamatoria del intestino.
BRPI0409139A (pt) combinação de ingredientes ativos de óleos que contêm ácido graxo w3 com extratos de plantas que contêm polifenol e uso destes
CL2008000088A1 (es) Compuestos derivados de 2,4-dioxo-pirimidina condensada; su proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; combinacion farmaceutica que comprende a dichos compuestos; y su uso para tratar un estado de enfermedad m

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/01/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/02/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B15V Prolongation of time limit allowed